nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP2D6—epilepsy syndrome	0.134	1	CbGaD
Zalcitabine—SLC22A7—Valproic Acid—epilepsy syndrome	0.0311	0.0582	CbGbCtD
Zalcitabine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0241	0.0452	CbGbCtD
Zalcitabine—CYP3A7—Carbamazepine—epilepsy syndrome	0.0202	0.0378	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0202	0.0378	CbGbCtD
Zalcitabine—CYP3A7—Phenytoin—epilepsy syndrome	0.0181	0.0339	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0181	0.0339	CbGbCtD
Zalcitabine—SLC22A6—Acetazolamide—epilepsy syndrome	0.0177	0.0331	CbGbCtD
Zalcitabine—CYP3A7—Phenobarbital—epilepsy syndrome	0.0161	0.0302	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0161	0.0302	CbGbCtD
Zalcitabine—CYP3A7—Midazolam—epilepsy syndrome	0.0159	0.0298	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0159	0.0298	CbGbCtD
Zalcitabine—CYP3A7—Diazepam—epilepsy syndrome	0.0153	0.0287	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0153	0.0287	CbGbCtD
Zalcitabine—CYP3A5—Carbamazepine—epilepsy syndrome	0.0151	0.0284	CbGbCtD
Zalcitabine—CYP2C9—Trimethadione—epilepsy syndrome	0.015	0.0282	CbGbCtD
Zalcitabine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0141	0.0265	CbGbCtD
Zalcitabine—CYP3A5—Phenytoin—epilepsy syndrome	0.0136	0.0255	CbGbCtD
Zalcitabine—SLC22A6—Valproic Acid—epilepsy syndrome	0.0132	0.0248	CbGbCtD
Zalcitabine—CYP3A5—Phenobarbital—epilepsy syndrome	0.0121	0.0227	CbGbCtD
Zalcitabine—CYP3A5—Midazolam—epilepsy syndrome	0.0119	0.0224	CbGbCtD
Zalcitabine—CYP3A5—Diazepam—epilepsy syndrome	0.0115	0.0215	CbGbCtD
Zalcitabine—CYP2C9—Carbamazepine—epilepsy syndrome	0.0102	0.019	CbGbCtD
Zalcitabine—CYP2C9—Primidone—epilepsy syndrome	0.00948	0.0178	CbGbCtD
Zalcitabine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0094	0.0176	CbGbCtD
Zalcitabine—CYP2C9—Phenytoin—epilepsy syndrome	0.00911	0.0171	CbGbCtD
Zalcitabine—CYP3A5—Valproic Acid—epilepsy syndrome	0.00905	0.017	CbGbCtD
Zalcitabine—CYP3A4—Felbamate—epilepsy syndrome	0.00874	0.0164	CbGbCtD
Zalcitabine—CYP3A4—Trimethadione—epilepsy syndrome	0.00874	0.0164	CbGbCtD
Zalcitabine—CYP2C9—Propofol—epilepsy syndrome	0.00849	0.0159	CbGbCtD
Zalcitabine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00822	0.0154	CbGbCtD
Zalcitabine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00812	0.0152	CbGbCtD
Zalcitabine—CYP2D6—Propofol—epilepsy syndrome	0.00777	0.0146	CbGbCtD
Zalcitabine—CYP2C9—Diazepam—epilepsy syndrome	0.0077	0.0144	CbGbCtD
Zalcitabine—CYP3A4—Clonazepam—epilepsy syndrome	0.00743	0.0139	CbGbCtD
Zalcitabine—CYP3A4—Clobazam—epilepsy syndrome	0.00713	0.0134	CbGbCtD
Zalcitabine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00607	0.0114	CbGbCtD
Zalcitabine—CYP3A4—Rufinamide—epilepsy syndrome	0.00606	0.0114	CbGbCtD
Zalcitabine—CYP3A4—Carbamazepine—epilepsy syndrome	0.0059	0.0111	CbGbCtD
Zalcitabine—CYP3A4—Primidone—epilepsy syndrome	0.00551	0.0103	CbGbCtD
Zalcitabine—CYP3A4—Phenytoin—epilepsy syndrome	0.0053	0.00992	CbGbCtD
Zalcitabine—CYP3A4—Propofol—epilepsy syndrome	0.00494	0.00926	CbGbCtD
Zalcitabine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00472	0.00885	CbGbCtD
Zalcitabine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00472	0.00885	CbGbCtD
Zalcitabine—CYP3A4—Midazolam—epilepsy syndrome	0.00465	0.00872	CbGbCtD
Zalcitabine—CYP3A4—Diazepam—epilepsy syndrome	0.00447	0.00839	CbGbCtD
Zalcitabine—CYP3A4—Zonisamide—epilepsy syndrome	0.00437	0.00818	CbGbCtD
Zalcitabine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00353	0.00661	CbGbCtD
Zalcitabine—CYP3A4—Topiramate—epilepsy syndrome	0.00318	0.00596	CbGbCtD
Zalcitabine—Cytarabine—NT5E—epilepsy syndrome	0.0017	0.624	CrCbGaD
Zalcitabine—DCK—Niclosamide—Clonazepam—epilepsy syndrome	0.000797	1	CbGdCrCtD
Zalcitabine—Lamivudine—ABCC2—epilepsy syndrome	0.000386	0.142	CrCbGaD
Zalcitabine—Lamivudine—ABCG2—epilepsy syndrome	0.000341	0.125	CrCbGaD
Zalcitabine—Gemcitabine—ABCB1—epilepsy syndrome	0.000156	0.0572	CrCbGaD
Zalcitabine—Lamivudine—ABCB1—epilepsy syndrome	0.000142	0.0521	CrCbGaD
Zalcitabine—Rash—Fosphenytoin—epilepsy syndrome	3.63e-05	0.000149	CcSEcCtD
Zalcitabine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.63e-05	0.000149	CcSEcCtD
Zalcitabine—Nervousness—Gabapentin—epilepsy syndrome	3.62e-05	0.000148	CcSEcCtD
Zalcitabine—Asthenia—Clonazepam—epilepsy syndrome	3.62e-05	0.000148	CcSEcCtD
Zalcitabine—Rhinitis—Topiramate—epilepsy syndrome	3.61e-05	0.000148	CcSEcCtD
Zalcitabine—Back pain—Gabapentin—epilepsy syndrome	3.61e-05	0.000148	CcSEcCtD
Zalcitabine—Headache—Fosphenytoin—epilepsy syndrome	3.61e-05	0.000148	CcSEcCtD
Zalcitabine—Hepatitis—Topiramate—epilepsy syndrome	3.61e-05	0.000148	CcSEcCtD
Zalcitabine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.6e-05	0.000147	CcSEcCtD
Zalcitabine—Palpitations—Pregabalin—epilepsy syndrome	3.6e-05	0.000147	CcSEcCtD
Zalcitabine—Asthenia—Phenytoin—epilepsy syndrome	3.59e-05	0.000147	CcSEcCtD
Zalcitabine—Hallucination—Topiramate—epilepsy syndrome	3.59e-05	0.000147	CcSEcCtD
Zalcitabine—Muscle spasms—Gabapentin—epilepsy syndrome	3.59e-05	0.000147	CcSEcCtD
Zalcitabine—Tachycardia—Valproic Acid—epilepsy syndrome	3.58e-05	0.000147	CcSEcCtD
Zalcitabine—Diarrhoea—Zonisamide—epilepsy syndrome	3.58e-05	0.000147	CcSEcCtD
Zalcitabine—Pharyngitis—Topiramate—epilepsy syndrome	3.58e-05	0.000147	CcSEcCtD
Zalcitabine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.58e-05	0.000147	CcSEcCtD
Zalcitabine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.58e-05	0.000147	CcSEcCtD
Zalcitabine—Pruritus—Clonazepam—epilepsy syndrome	3.57e-05	0.000146	CcSEcCtD
Zalcitabine—Vomiting—Vigabatrin—epilepsy syndrome	3.57e-05	0.000146	CcSEcCtD
Zalcitabine—Skin disorder—Valproic Acid—epilepsy syndrome	3.57e-05	0.000146	CcSEcCtD
Zalcitabine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.55e-05	0.000145	CcSEcCtD
Zalcitabine—Cough—Pregabalin—epilepsy syndrome	3.55e-05	0.000145	CcSEcCtD
Zalcitabine—Pruritus—Phenytoin—epilepsy syndrome	3.54e-05	0.000145	CcSEcCtD
Zalcitabine—Rash—Vigabatrin—epilepsy syndrome	3.54e-05	0.000145	CcSEcCtD
Zalcitabine—Dizziness—Felbamate—epilepsy syndrome	3.54e-05	0.000145	CcSEcCtD
Zalcitabine—Dermatitis—Vigabatrin—epilepsy syndrome	3.53e-05	0.000145	CcSEcCtD
Zalcitabine—Pruritus—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.000144	CcSEcCtD
Zalcitabine—Convulsion—Pregabalin—epilepsy syndrome	3.53e-05	0.000144	CcSEcCtD
Zalcitabine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.52e-05	0.000144	CcSEcCtD
Zalcitabine—Vision blurred—Gabapentin—epilepsy syndrome	3.52e-05	0.000144	CcSEcCtD
Zalcitabine—Headache—Vigabatrin—epilepsy syndrome	3.52e-05	0.000144	CcSEcCtD
Zalcitabine—Hypertension—Pregabalin—epilepsy syndrome	3.51e-05	0.000144	CcSEcCtD
Zalcitabine—Vomiting—Diazepam—epilepsy syndrome	3.51e-05	0.000144	CcSEcCtD
Zalcitabine—Anorexia—Valproic Acid—epilepsy syndrome	3.5e-05	0.000143	CcSEcCtD
Zalcitabine—Tremor—Gabapentin—epilepsy syndrome	3.5e-05	0.000143	CcSEcCtD
Zalcitabine—Rash—Diazepam—epilepsy syndrome	3.48e-05	0.000143	CcSEcCtD
Zalcitabine—Dermatitis—Diazepam—epilepsy syndrome	3.48e-05	0.000143	CcSEcCtD
Zalcitabine—Visual impairment—Topiramate—epilepsy syndrome	3.47e-05	0.000142	CcSEcCtD
Zalcitabine—Arthralgia—Pregabalin—epilepsy syndrome	3.46e-05	0.000142	CcSEcCtD
Zalcitabine—Myalgia—Pregabalin—epilepsy syndrome	3.46e-05	0.000142	CcSEcCtD
Zalcitabine—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.46e-05	0.000142	CcSEcCtD
Zalcitabine—Dizziness—Zonisamide—epilepsy syndrome	3.46e-05	0.000142	CcSEcCtD
Zalcitabine—Headache—Diazepam—epilepsy syndrome	3.46e-05	0.000142	CcSEcCtD
Zalcitabine—Anxiety—Pregabalin—epilepsy syndrome	3.45e-05	0.000141	CcSEcCtD
Zalcitabine—Diarrhoea—Clonazepam—epilepsy syndrome	3.45e-05	0.000141	CcSEcCtD
Zalcitabine—Anaemia—Gabapentin—epilepsy syndrome	3.45e-05	0.000141	CcSEcCtD
Zalcitabine—Asthenia—Carbamazepine—epilepsy syndrome	3.43e-05	0.000141	CcSEcCtD
Zalcitabine—Agitation—Gabapentin—epilepsy syndrome	3.43e-05	0.00014	CcSEcCtD
Zalcitabine—Diarrhoea—Phenytoin—epilepsy syndrome	3.43e-05	0.00014	CcSEcCtD
Zalcitabine—Discomfort—Pregabalin—epilepsy syndrome	3.42e-05	0.00014	CcSEcCtD
Zalcitabine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.41e-05	0.00014	CcSEcCtD
Zalcitabine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.41e-05	0.00014	CcSEcCtD
Zalcitabine—Vomiting—Felbamate—epilepsy syndrome	3.4e-05	0.000139	CcSEcCtD
Zalcitabine—Dry mouth—Pregabalin—epilepsy syndrome	3.39e-05	0.000139	CcSEcCtD
Zalcitabine—Pruritus—Carbamazepine—epilepsy syndrome	3.38e-05	0.000139	CcSEcCtD
Zalcitabine—Rash—Felbamate—epilepsy syndrome	3.37e-05	0.000138	CcSEcCtD
Zalcitabine—Eye disorder—Topiramate—epilepsy syndrome	3.37e-05	0.000138	CcSEcCtD
Zalcitabine—Dermatitis—Felbamate—epilepsy syndrome	3.37e-05	0.000138	CcSEcCtD
Zalcitabine—Malaise—Gabapentin—epilepsy syndrome	3.36e-05	0.000138	CcSEcCtD
Zalcitabine—Tinnitus—Topiramate—epilepsy syndrome	3.36e-05	0.000138	CcSEcCtD
Zalcitabine—Vertigo—Gabapentin—epilepsy syndrome	3.35e-05	0.000137	CcSEcCtD
Zalcitabine—Headache—Felbamate—epilepsy syndrome	3.35e-05	0.000137	CcSEcCtD
Zalcitabine—Confusional state—Pregabalin—epilepsy syndrome	3.35e-05	0.000137	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.35e-05	0.000137	CcSEcCtD
Zalcitabine—Flushing—Topiramate—epilepsy syndrome	3.35e-05	0.000137	CcSEcCtD
Zalcitabine—Syncope—Gabapentin—epilepsy syndrome	3.35e-05	0.000137	CcSEcCtD
Zalcitabine—Leukopenia—Gabapentin—epilepsy syndrome	3.34e-05	0.000137	CcSEcCtD
Zalcitabine—Dizziness—Clonazepam—epilepsy syndrome	3.34e-05	0.000137	CcSEcCtD
Zalcitabine—Vomiting—Zonisamide—epilepsy syndrome	3.33e-05	0.000136	CcSEcCtD
Zalcitabine—Insomnia—Valproic Acid—epilepsy syndrome	3.32e-05	0.000136	CcSEcCtD
Zalcitabine—Oedema—Pregabalin—epilepsy syndrome	3.32e-05	0.000136	CcSEcCtD
Zalcitabine—Asthenia—Lamotrigine—epilepsy syndrome	3.32e-05	0.000136	CcSEcCtD
Zalcitabine—Dizziness—Phenytoin—epilepsy syndrome	3.31e-05	0.000136	CcSEcCtD
Zalcitabine—Rash—Zonisamide—epilepsy syndrome	3.3e-05	0.000135	CcSEcCtD
Zalcitabine—Infection—Pregabalin—epilepsy syndrome	3.3e-05	0.000135	CcSEcCtD
Zalcitabine—Palpitations—Gabapentin—epilepsy syndrome	3.3e-05	0.000135	CcSEcCtD
Zalcitabine—Dermatitis—Zonisamide—epilepsy syndrome	3.3e-05	0.000135	CcSEcCtD
Zalcitabine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.3e-05	0.000135	CcSEcCtD
Zalcitabine—Loss of consciousness—Gabapentin—epilepsy syndrome	3.28e-05	0.000134	CcSEcCtD
Zalcitabine—Headache—Zonisamide—epilepsy syndrome	3.28e-05	0.000134	CcSEcCtD
Zalcitabine—Dyspnoea—Valproic Acid—epilepsy syndrome	3.27e-05	0.000134	CcSEcCtD
Zalcitabine—Diarrhoea—Carbamazepine—epilepsy syndrome	3.27e-05	0.000134	CcSEcCtD
Zalcitabine—Pruritus—Lamotrigine—epilepsy syndrome	3.27e-05	0.000134	CcSEcCtD
Zalcitabine—Shock—Pregabalin—epilepsy syndrome	3.27e-05	0.000134	CcSEcCtD
Zalcitabine—Somnolence—Valproic Acid—epilepsy syndrome	3.27e-05	0.000134	CcSEcCtD
Zalcitabine—Cough—Gabapentin—epilepsy syndrome	3.26e-05	0.000133	CcSEcCtD
Zalcitabine—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.25e-05	0.000133	CcSEcCtD
Zalcitabine—Tachycardia—Pregabalin—epilepsy syndrome	3.24e-05	0.000133	CcSEcCtD
Zalcitabine—Chills—Topiramate—epilepsy syndrome	3.24e-05	0.000133	CcSEcCtD
Zalcitabine—Dyspepsia—Valproic Acid—epilepsy syndrome	3.23e-05	0.000132	CcSEcCtD
Zalcitabine—Convulsion—Gabapentin—epilepsy syndrome	3.23e-05	0.000132	CcSEcCtD
Zalcitabine—Skin disorder—Pregabalin—epilepsy syndrome	3.23e-05	0.000132	CcSEcCtD
Zalcitabine—Hypertension—Gabapentin—epilepsy syndrome	3.22e-05	0.000132	CcSEcCtD
Zalcitabine—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.21e-05	0.000132	CcSEcCtD
Zalcitabine—Vomiting—Clonazepam—epilepsy syndrome	3.21e-05	0.000131	CcSEcCtD
Zalcitabine—Decreased appetite—Valproic Acid—epilepsy syndrome	3.19e-05	0.000131	CcSEcCtD
Zalcitabine—Alopecia—Topiramate—epilepsy syndrome	3.19e-05	0.000131	CcSEcCtD
Zalcitabine—Vomiting—Phenytoin—epilepsy syndrome	3.19e-05	0.000131	CcSEcCtD
Zalcitabine—Rash—Clonazepam—epilepsy syndrome	3.18e-05	0.00013	CcSEcCtD
Zalcitabine—Dermatitis—Clonazepam—epilepsy syndrome	3.18e-05	0.00013	CcSEcCtD
Zalcitabine—Arthralgia—Gabapentin—epilepsy syndrome	3.18e-05	0.00013	CcSEcCtD
Zalcitabine—Myalgia—Gabapentin—epilepsy syndrome	3.18e-05	0.00013	CcSEcCtD
Zalcitabine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.00013	CcSEcCtD
Zalcitabine—Fatigue—Valproic Acid—epilepsy syndrome	3.17e-05	0.00013	CcSEcCtD
Zalcitabine—Anxiety—Gabapentin—epilepsy syndrome	3.17e-05	0.00013	CcSEcCtD
Zalcitabine—Anorexia—Pregabalin—epilepsy syndrome	3.17e-05	0.00013	CcSEcCtD
Zalcitabine—Dizziness—Carbamazepine—epilepsy syndrome	3.16e-05	0.00013	CcSEcCtD
Zalcitabine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.16e-05	0.00013	CcSEcCtD
Zalcitabine—Headache—Clonazepam—epilepsy syndrome	3.16e-05	0.000129	CcSEcCtD
Zalcitabine—Rash—Phenytoin—epilepsy syndrome	3.16e-05	0.000129	CcSEcCtD
Zalcitabine—Dermatitis—Phenytoin—epilepsy syndrome	3.16e-05	0.000129	CcSEcCtD
Zalcitabine—Rash—Oxcarbazepine—epilepsy syndrome	3.14e-05	0.000129	CcSEcCtD
Zalcitabine—Pain—Valproic Acid—epilepsy syndrome	3.14e-05	0.000129	CcSEcCtD
Zalcitabine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.14e-05	0.000129	CcSEcCtD
Zalcitabine—Headache—Phenytoin—epilepsy syndrome	3.14e-05	0.000129	CcSEcCtD
Zalcitabine—Discomfort—Gabapentin—epilepsy syndrome	3.14e-05	0.000129	CcSEcCtD
Zalcitabine—Headache—Oxcarbazepine—epilepsy syndrome	3.12e-05	0.000128	CcSEcCtD
Zalcitabine—Dry mouth—Gabapentin—epilepsy syndrome	3.11e-05	0.000127	CcSEcCtD
Zalcitabine—Flatulence—Topiramate—epilepsy syndrome	3.09e-05	0.000127	CcSEcCtD
Zalcitabine—Tension—Topiramate—epilepsy syndrome	3.08e-05	0.000126	CcSEcCtD
Zalcitabine—Dysgeusia—Topiramate—epilepsy syndrome	3.07e-05	0.000126	CcSEcCtD
Zalcitabine—Confusional state—Gabapentin—epilepsy syndrome	3.07e-05	0.000126	CcSEcCtD
Zalcitabine—Dizziness—Lamotrigine—epilepsy syndrome	3.06e-05	0.000125	CcSEcCtD
Zalcitabine—Nervousness—Topiramate—epilepsy syndrome	3.05e-05	0.000125	CcSEcCtD
Zalcitabine—Oedema—Gabapentin—epilepsy syndrome	3.04e-05	0.000125	CcSEcCtD
Zalcitabine—Vomiting—Carbamazepine—epilepsy syndrome	3.04e-05	0.000125	CcSEcCtD
Zalcitabine—Back pain—Topiramate—epilepsy syndrome	3.04e-05	0.000124	CcSEcCtD
Zalcitabine—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.03e-05	0.000124	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.03e-05	0.000124	CcSEcCtD
Zalcitabine—Infection—Gabapentin—epilepsy syndrome	3.02e-05	0.000124	CcSEcCtD
Zalcitabine—Muscle spasms—Topiramate—epilepsy syndrome	3.02e-05	0.000124	CcSEcCtD
Zalcitabine—Rash—Carbamazepine—epilepsy syndrome	3.02e-05	0.000124	CcSEcCtD
Zalcitabine—Dermatitis—Carbamazepine—epilepsy syndrome	3.01e-05	0.000123	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3e-05	0.000123	CcSEcCtD
Zalcitabine—Insomnia—Pregabalin—epilepsy syndrome	3e-05	0.000123	CcSEcCtD
Zalcitabine—Headache—Carbamazepine—epilepsy syndrome	3e-05	0.000123	CcSEcCtD
Zalcitabine—Shock—Gabapentin—epilepsy syndrome	3e-05	0.000123	CcSEcCtD
Zalcitabine—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.98e-05	0.000122	CcSEcCtD
Zalcitabine—Tachycardia—Gabapentin—epilepsy syndrome	2.97e-05	0.000122	CcSEcCtD
Zalcitabine—Dyspnoea—Pregabalin—epilepsy syndrome	2.96e-05	0.000121	CcSEcCtD
Zalcitabine—Vision blurred—Topiramate—epilepsy syndrome	2.96e-05	0.000121	CcSEcCtD
Zalcitabine—Skin disorder—Gabapentin—epilepsy syndrome	2.96e-05	0.000121	CcSEcCtD
Zalcitabine—Somnolence—Pregabalin—epilepsy syndrome	2.95e-05	0.000121	CcSEcCtD
Zalcitabine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.94e-05	0.000121	CcSEcCtD
Zalcitabine—Tremor—Topiramate—epilepsy syndrome	2.94e-05	0.00012	CcSEcCtD
Zalcitabine—Vomiting—Lamotrigine—epilepsy syndrome	2.94e-05	0.00012	CcSEcCtD
Zalcitabine—Urticaria—Valproic Acid—epilepsy syndrome	2.92e-05	0.00012	CcSEcCtD
Zalcitabine—Rash—Lamotrigine—epilepsy syndrome	2.91e-05	0.000119	CcSEcCtD
Zalcitabine—Ill-defined disorder—Topiramate—epilepsy syndrome	2.91e-05	0.000119	CcSEcCtD
Zalcitabine—Dermatitis—Lamotrigine—epilepsy syndrome	2.91e-05	0.000119	CcSEcCtD
Zalcitabine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.9e-05	0.000119	CcSEcCtD
Zalcitabine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.9e-05	0.000119	CcSEcCtD
Zalcitabine—Anorexia—Gabapentin—epilepsy syndrome	2.9e-05	0.000119	CcSEcCtD
Zalcitabine—Anaemia—Topiramate—epilepsy syndrome	2.9e-05	0.000119	CcSEcCtD
Zalcitabine—Headache—Lamotrigine—epilepsy syndrome	2.9e-05	0.000119	CcSEcCtD
Zalcitabine—Decreased appetite—Pregabalin—epilepsy syndrome	2.89e-05	0.000118	CcSEcCtD
Zalcitabine—Agitation—Topiramate—epilepsy syndrome	2.88e-05	0.000118	CcSEcCtD
Zalcitabine—Fatigue—Pregabalin—epilepsy syndrome	2.86e-05	0.000117	CcSEcCtD
Zalcitabine—Pain—Pregabalin—epilepsy syndrome	2.84e-05	0.000116	CcSEcCtD
Zalcitabine—Malaise—Topiramate—epilepsy syndrome	2.83e-05	0.000116	CcSEcCtD
Zalcitabine—Vertigo—Topiramate—epilepsy syndrome	2.82e-05	0.000116	CcSEcCtD
Zalcitabine—Syncope—Topiramate—epilepsy syndrome	2.81e-05	0.000115	CcSEcCtD
Zalcitabine—Leukopenia—Topiramate—epilepsy syndrome	2.81e-05	0.000115	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.77e-05	0.000114	CcSEcCtD
Zalcitabine—Palpitations—Topiramate—epilepsy syndrome	2.77e-05	0.000114	CcSEcCtD
Zalcitabine—Loss of consciousness—Topiramate—epilepsy syndrome	2.76e-05	0.000113	CcSEcCtD
Zalcitabine—Insomnia—Gabapentin—epilepsy syndrome	2.75e-05	0.000113	CcSEcCtD
Zalcitabine—Cough—Topiramate—epilepsy syndrome	2.74e-05	0.000112	CcSEcCtD
Zalcitabine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.74e-05	0.000112	CcSEcCtD
Zalcitabine—Convulsion—Topiramate—epilepsy syndrome	2.72e-05	0.000111	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.72e-05	0.000111	CcSEcCtD
Zalcitabine—Dyspnoea—Gabapentin—epilepsy syndrome	2.71e-05	0.000111	CcSEcCtD
Zalcitabine—Hypertension—Topiramate—epilepsy syndrome	2.71e-05	0.000111	CcSEcCtD
Zalcitabine—Somnolence—Gabapentin—epilepsy syndrome	2.71e-05	0.000111	CcSEcCtD
Zalcitabine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.71e-05	0.000111	CcSEcCtD
Zalcitabine—Dyspepsia—Gabapentin—epilepsy syndrome	2.68e-05	0.00011	CcSEcCtD
Zalcitabine—Myalgia—Topiramate—epilepsy syndrome	2.67e-05	0.000109	CcSEcCtD
Zalcitabine—Arthralgia—Topiramate—epilepsy syndrome	2.67e-05	0.000109	CcSEcCtD
Zalcitabine—Anxiety—Topiramate—epilepsy syndrome	2.66e-05	0.000109	CcSEcCtD
Zalcitabine—Decreased appetite—Gabapentin—epilepsy syndrome	2.65e-05	0.000108	CcSEcCtD
Zalcitabine—Discomfort—Topiramate—epilepsy syndrome	2.64e-05	0.000108	CcSEcCtD
Zalcitabine—Urticaria—Pregabalin—epilepsy syndrome	2.64e-05	0.000108	CcSEcCtD
Zalcitabine—Asthenia—Valproic Acid—epilepsy syndrome	2.64e-05	0.000108	CcSEcCtD
Zalcitabine—Fatigue—Gabapentin—epilepsy syndrome	2.63e-05	0.000108	CcSEcCtD
Zalcitabine—Body temperature increased—Pregabalin—epilepsy syndrome	2.62e-05	0.000108	CcSEcCtD
Zalcitabine—Abdominal pain—Pregabalin—epilepsy syndrome	2.62e-05	0.000108	CcSEcCtD
Zalcitabine—Dry mouth—Topiramate—epilepsy syndrome	2.61e-05	0.000107	CcSEcCtD
Zalcitabine—Pain—Gabapentin—epilepsy syndrome	2.6e-05	0.000107	CcSEcCtD
Zalcitabine—Pruritus—Valproic Acid—epilepsy syndrome	2.6e-05	0.000106	CcSEcCtD
Zalcitabine—Confusional state—Topiramate—epilepsy syndrome	2.58e-05	0.000106	CcSEcCtD
Zalcitabine—Oedema—Topiramate—epilepsy syndrome	2.56e-05	0.000105	CcSEcCtD
Zalcitabine—Infection—Topiramate—epilepsy syndrome	2.54e-05	0.000104	CcSEcCtD
Zalcitabine—Shock—Topiramate—epilepsy syndrome	2.52e-05	0.000103	CcSEcCtD
Zalcitabine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.51e-05	0.000103	CcSEcCtD
Zalcitabine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.51e-05	0.000103	CcSEcCtD
Zalcitabine—Thrombocytopenia—Topiramate—epilepsy syndrome	2.51e-05	0.000103	CcSEcCtD
Zalcitabine—Tachycardia—Topiramate—epilepsy syndrome	2.5e-05	0.000102	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.49e-05	0.000102	CcSEcCtD
Zalcitabine—Skin disorder—Topiramate—epilepsy syndrome	2.49e-05	0.000102	CcSEcCtD
Zalcitabine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.48e-05	0.000101	CcSEcCtD
Zalcitabine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.45e-05	0.0001	CcSEcCtD
Zalcitabine—Anorexia—Topiramate—epilepsy syndrome	2.44e-05	0.0001	CcSEcCtD
Zalcitabine—Dizziness—Valproic Acid—epilepsy syndrome	2.43e-05	9.95e-05	CcSEcCtD
Zalcitabine—Urticaria—Gabapentin—epilepsy syndrome	2.42e-05	9.91e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Gabapentin—epilepsy syndrome	2.41e-05	9.86e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Gabapentin—epilepsy syndrome	2.41e-05	9.86e-05	CcSEcCtD
Zalcitabine—Asthenia—Pregabalin—epilepsy syndrome	2.38e-05	9.76e-05	CcSEcCtD
Zalcitabine—Pruritus—Pregabalin—epilepsy syndrome	2.35e-05	9.63e-05	CcSEcCtD
Zalcitabine—Vomiting—Valproic Acid—epilepsy syndrome	2.34e-05	9.57e-05	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.33e-05	9.56e-05	CcSEcCtD
Zalcitabine—Insomnia—Topiramate—epilepsy syndrome	2.32e-05	9.49e-05	CcSEcCtD
Zalcitabine—Rash—Valproic Acid—epilepsy syndrome	2.32e-05	9.49e-05	CcSEcCtD
Zalcitabine—Dermatitis—Valproic Acid—epilepsy syndrome	2.31e-05	9.48e-05	CcSEcCtD
Zalcitabine—Headache—Valproic Acid—epilepsy syndrome	2.3e-05	9.43e-05	CcSEcCtD
Zalcitabine—Dyspnoea—Topiramate—epilepsy syndrome	2.28e-05	9.36e-05	CcSEcCtD
Zalcitabine—Somnolence—Topiramate—epilepsy syndrome	2.28e-05	9.33e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Pregabalin—epilepsy syndrome	2.27e-05	9.31e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Topiramate—epilepsy syndrome	2.25e-05	9.24e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.24e-05	9.19e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Topiramate—epilepsy syndrome	2.23e-05	9.12e-05	CcSEcCtD
Zalcitabine—Fatigue—Topiramate—epilepsy syndrome	2.21e-05	9.05e-05	CcSEcCtD
Zalcitabine—Dizziness—Pregabalin—epilepsy syndrome	2.2e-05	9e-05	CcSEcCtD
Zalcitabine—Pain—Topiramate—epilepsy syndrome	2.19e-05	8.98e-05	CcSEcCtD
Zalcitabine—Asthenia—Gabapentin—epilepsy syndrome	2.18e-05	8.95e-05	CcSEcCtD
Zalcitabine—Pruritus—Gabapentin—epilepsy syndrome	2.15e-05	8.83e-05	CcSEcCtD
Zalcitabine—Vomiting—Pregabalin—epilepsy syndrome	2.11e-05	8.65e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Topiramate—epilepsy syndrome	2.11e-05	8.65e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.09e-05	8.58e-05	CcSEcCtD
Zalcitabine—Rash—Pregabalin—epilepsy syndrome	2.09e-05	8.58e-05	CcSEcCtD
Zalcitabine—Dermatitis—Pregabalin—epilepsy syndrome	2.09e-05	8.57e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Gabapentin—epilepsy syndrome	2.08e-05	8.54e-05	CcSEcCtD
Zalcitabine—Headache—Pregabalin—epilepsy syndrome	2.08e-05	8.52e-05	CcSEcCtD
Zalcitabine—Urticaria—Topiramate—epilepsy syndrome	2.04e-05	8.34e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Topiramate—epilepsy syndrome	2.03e-05	8.3e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Topiramate—epilepsy syndrome	2.03e-05	8.3e-05	CcSEcCtD
Zalcitabine—Dizziness—Gabapentin—epilepsy syndrome	2.01e-05	8.25e-05	CcSEcCtD
Zalcitabine—Vomiting—Gabapentin—epilepsy syndrome	1.94e-05	7.93e-05	CcSEcCtD
Zalcitabine—Rash—Gabapentin—epilepsy syndrome	1.92e-05	7.87e-05	CcSEcCtD
Zalcitabine—Dermatitis—Gabapentin—epilepsy syndrome	1.92e-05	7.86e-05	CcSEcCtD
Zalcitabine—Headache—Gabapentin—epilepsy syndrome	1.91e-05	7.82e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Topiramate—epilepsy syndrome	1.89e-05	7.73e-05	CcSEcCtD
Zalcitabine—Asthenia—Topiramate—epilepsy syndrome	1.84e-05	7.53e-05	CcSEcCtD
Zalcitabine—Pruritus—Topiramate—epilepsy syndrome	1.81e-05	7.43e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Topiramate—epilepsy syndrome	1.75e-05	7.18e-05	CcSEcCtD
Zalcitabine—Dizziness—Topiramate—epilepsy syndrome	1.69e-05	6.94e-05	CcSEcCtD
Zalcitabine—Vomiting—Topiramate—epilepsy syndrome	1.63e-05	6.67e-05	CcSEcCtD
Zalcitabine—Rash—Topiramate—epilepsy syndrome	1.62e-05	6.62e-05	CcSEcCtD
Zalcitabine—Dermatitis—Topiramate—epilepsy syndrome	1.61e-05	6.61e-05	CcSEcCtD
Zalcitabine—Headache—Topiramate—epilepsy syndrome	1.6e-05	6.58e-05	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—CACNA1D—epilepsy syndrome	1.37e-05	0.000162	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—UPB1—epilepsy syndrome	1.35e-05	0.00016	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ATIC—epilepsy syndrome	1.35e-05	0.00016	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NEU1—epilepsy syndrome	1.35e-05	0.00016	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GPX1—epilepsy syndrome	1.34e-05	0.000159	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GPX1—epilepsy syndrome	1.32e-05	0.000156	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	1.3e-05	0.000154	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.3e-05	0.000154	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TXNRD1—epilepsy syndrome	1.28e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	1.27e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GAMT—epilepsy syndrome	1.27e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	1.27e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PNPO—epilepsy syndrome	1.27e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.26e-05	0.000149	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.26e-05	0.000149	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.26e-05	0.000149	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.26e-05	0.000149	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GBE1—epilepsy syndrome	1.26e-05	0.000149	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	1.26e-05	0.000149	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AQP1—epilepsy syndrome	1.24e-05	0.000147	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.2e-05	0.000142	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	1.18e-05	0.00014	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—QDPR—epilepsy syndrome	1.18e-05	0.00014	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA4—epilepsy syndrome	1.18e-05	0.00014	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	1.18e-05	0.00014	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AGT—epilepsy syndrome	1.17e-05	0.000139	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.17e-05	0.000139	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.17e-05	0.000139	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.17e-05	0.000138	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AGT—epilepsy syndrome	1.16e-05	0.000137	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	1.15e-05	0.000136	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—APOE—epilepsy syndrome	1.15e-05	0.000136	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—APOE—epilepsy syndrome	1.13e-05	0.000134	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CHRM3—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—KCNJ11—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALAD—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NT5E—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—COX3—epilepsy syndrome	1.11e-05	0.000132	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.1e-05	0.00013	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	1.07e-05	0.000127	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	1.07e-05	0.000127	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.05e-05	0.000125	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.05e-05	0.000125	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.05e-05	0.000125	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.05e-05	0.000125	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.05e-05	0.000125	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	1.05e-05	0.000124	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.04e-05	0.000124	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.04e-05	0.000124	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.04e-05	0.000124	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.04e-05	0.000124	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.04e-05	0.000124	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADSL—epilepsy syndrome	1.03e-05	0.000122	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.02e-05	0.000121	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.01e-05	0.00012	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GLUL—epilepsy syndrome	1.01e-05	0.000119	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	9.88e-06	0.000117	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—POMC—epilepsy syndrome	9.88e-06	0.000117	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—POMC—epilepsy syndrome	9.73e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—UPB1—epilepsy syndrome	9.63e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NEU1—epilepsy syndrome	9.63e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ATIC—epilepsy syndrome	9.63e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—UPB1—epilepsy syndrome	9.55e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ATIC—epilepsy syndrome	9.55e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NEU1—epilepsy syndrome	9.55e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	9.27e-06	0.00011	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	9.24e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	9.19e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCG2—epilepsy syndrome	9.15e-06	0.000108	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.13e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	9.08e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	9.08e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	9.08e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADK—epilepsy syndrome	9.08e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	9.08e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	9.08e-06	0.000108	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ALB—epilepsy syndrome	9e-06	0.000107	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AQP1—epilepsy syndrome	8.97e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	8.95e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	8.95e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	8.92e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	8.88e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GBE1—epilepsy syndrome	8.88e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—epilepsy syndrome	8.87e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	8.86e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.67e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	8.42e-06	9.97e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	8.34e-06	9.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8.31e-06	9.84e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8.31e-06	9.84e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8.31e-06	9.84e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8.31e-06	9.84e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	8.19e-06	9.7e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	8.12e-06	9.62e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	8.11e-06	9.61e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	8.11e-06	9.61e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	8e-06	9.48e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	7.98e-06	9.46e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	7.98e-06	9.46e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NT5E—epilepsy syndrome	7.91e-06	9.37e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALAD—epilepsy syndrome	7.91e-06	9.37e-05	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—epilepsy syndrome	7.88e-06	9.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—epilepsy syndrome	7.76e-06	9.19e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.72e-06	9.15e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.72e-06	9.15e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.7e-06	9.12e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	7.61e-06	9.02e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	7.61e-06	9.02e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	7.61e-06	9.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—BCHE—epilepsy syndrome	7.58e-06	8.98e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	7.55e-06	8.94e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	7.55e-06	8.94e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	7.45e-06	8.83e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	7.38e-06	8.75e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	7.3e-06	8.65e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.26e-06	8.6e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADSL—epilepsy syndrome	7.23e-06	8.57e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	7.23e-06	8.57e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	7.16e-06	8.48e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	7.15e-06	8.48e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TH—epilepsy syndrome	7.13e-06	8.45e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GLUL—epilepsy syndrome	7.1e-06	8.41e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	7.02e-06	8.32e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.96e-06	8.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.88e-06	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.88e-06	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.88e-06	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.88e-06	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.88e-06	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	6.61e-06	7.84e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.57e-06	7.79e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.51e-06	7.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	6.45e-06	7.64e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	6.41e-06	7.59e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6.38e-06	7.56e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	6.32e-06	7.49e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.3e-06	7.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.3e-06	7.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.3e-06	7.46e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.07e-06	7.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.06e-06	7.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	5.95e-06	7.05e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CAT—epilepsy syndrome	5.87e-06	6.96e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.85e-06	6.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.85e-06	6.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	5.78e-06	6.85e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.77e-06	6.84e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.77e-06	6.84e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.72e-06	6.78e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.72e-06	6.78e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	5.71e-06	6.77e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.5e-06	6.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	5.5e-06	6.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—BCHE—epilepsy syndrome	5.48e-06	6.49e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.35e-06	6.34e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.33e-06	6.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPX1—epilepsy syndrome	5.31e-06	6.29e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	5.23e-06	6.19e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.22e-06	6.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.22e-06	6.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.22e-06	6.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	5.17e-06	6.13e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TH—epilepsy syndrome	5.15e-06	6.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.98e-06	5.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.98e-06	5.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.87e-06	5.77e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.77e-06	5.65e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.7e-06	5.57e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.68e-06	5.54e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.66e-06	5.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AGT—epilepsy syndrome	4.65e-06	5.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.59e-06	5.44e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.58e-06	5.43e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOE—epilepsy syndrome	4.56e-06	5.4e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.55e-06	5.4e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.54e-06	5.38e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.52e-06	5.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.48e-06	5.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	4.3e-06	5.1e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.3e-06	5.09e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CAT—epilepsy syndrome	4.24e-06	5.03e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.17e-06	4.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	4.13e-06	4.89e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.09e-06	4.84e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.08e-06	4.83e-05	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—epilepsy syndrome	3.96e-06	4.69e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—POMC—epilepsy syndrome	3.92e-06	4.64e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.91e-06	4.64e-05	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—epilepsy syndrome	3.9e-06	4.62e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.9e-06	4.62e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.88e-06	4.6e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.86e-06	4.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.84e-06	4.55e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.77e-06	4.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.77e-06	4.47e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.72e-06	4.4e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.69e-06	4.37e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.68e-06	4.36e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TH—epilepsy syndrome	3.66e-06	4.34e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.65e-06	4.32e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TH—epilepsy syndrome	3.63e-06	4.3e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.58e-06	4.24e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—epilepsy syndrome	3.57e-06	4.23e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AGT—epilepsy syndrome	3.36e-06	3.99e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOE—epilepsy syndrome	3.3e-06	3.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	3.13e-06	3.7e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.07e-06	3.64e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	3.06e-06	3.62e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.03e-06	3.59e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.02e-06	3.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3e-06	3.55e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.99e-06	3.54e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.98e-06	3.53e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.93e-06	3.48e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.91e-06	3.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.83e-06	3.36e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.73e-06	3.23e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.7e-06	3.21e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.69e-06	3.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.58e-06	3.06e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.56e-06	3.03e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.55e-06	3.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.43e-06	2.88e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.4e-06	2.85e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.4e-06	2.84e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.39e-06	2.84e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.37e-06	2.81e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.34e-06	2.78e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.32e-06	2.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	2.26e-06	2.68e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.01e-06	2.39e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2e-06	2.37e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—POMC—epilepsy syndrome	2e-06	2.37e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.97e-06	2.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.92e-06	2.27e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.84e-06	2.18e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.82e-06	2.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.78e-06	2.11e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.61e-06	1.9e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.59e-06	1.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.57e-06	1.86e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.56e-06	1.85e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.53e-06	1.82e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.32e-06	1.56e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.2e-06	1.42e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.14e-06	1.35e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.05e-06	1.24e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	8.07e-07	9.57e-06	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	8e-07	9.48e-06	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.28e-07	6.25e-06	CbGpPWpGaD
